GlassScriptPhysician profile
Jeffrey L Williams
NPI 1588696553
$1,481.13
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $930 · 2020: $551.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $386.86 | 2019-2020 | |
| Amarin Pharma, INC. | $321.14 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $212.41 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $123.63 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $115.67 | 2019-2020 | |
| Lilly USA, LLC | $95.16 | 2019 | |
| Pfizer INC. | $72.54 | 2020 | |
| Amgen INC. | $30.01 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.38 | 2019-2020 | |
| Genentech USA, INC. | $24.13 | 2019 | |
| Novartis Pharmaceuticals Corporation | $22.34 | 2019 | |
| Optinose US, INC. | $17.04 | 2020 | |
| Esperion Therapeutics, INC. | $16.71 | 2020 | |
| Axonics, INC. | $15.11 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Williams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.